NeoGenomics, Inc.

Good day, ladies and gentlemen, and welcome to the Neogenomics fourth quarter and full year 2021 earnings call. At this time, all participants have been placed on the listen-only mode, and the floor will be open for questions and comments after the presentation. It is now my pleasure to turn the floor over to your host, Chief Executive Officer Mark Mallon. Sir, the floor is yours.

Thanks, Holly. Good morning, everyone. I'd like to welcome you to NeoGenomics' fourth quarter and full year 2021 conference call. Joining me on this call from our Fort Myers headquarters are Bill Bonello, our Chief Financial Officer, George Cardoza, President and Chief Operating Officer of our Lab Operations, Doug Brown, our Chief Strategy and Corporate Development Officer, and Charlie Edson, our Director of Investor Relations. Joining on the phone are Dr. Gina Waller, President of our Farmer Services Division, Dr. Clive Morris, President of Innovata, and Clint Taylor, President of our Informatics Division. Before we begin our prepared remarks, Charlie will discuss the forward-looking statements and the non-GAAP measures used on this call.

This conference call includes forward-looking statements about our 2022 initiatives, 2022 financial outlooks, growth opportunities, and anticipated operating results and performance. Each forward-looking statement is subject to risks and uncertainties that could cause actual results to differ materially from those projected in such statements. Additional information regarding these risk factors appears under the heading forward-looking statements in the press release we issued this morning and in the risk factors section of our annual report on Form 10-K for the year ended December 31, 2021 that is filed with the Securities and Exchange Commission and available at www.scc.gov and on our website at www.neogenomics.com, as well as subsequent filings of the SEC. The forward-looking statements made during this call speak only as of the original date of the call, and we undertake no obligation to update or revise any of these statements. In addition, during the conference call, in order to give greater transparency regarding our operating performance, we refer to certain non-GAAP financial measures that involve adjustments to GAAP results. These non-GAAP financial measures presented should not be considered to be an alternative to financial measures required by GAAP, should not be considered measures of liquidity, and are unlikely to be comparable to non-GAAP financial measures provided by other companies. Any non-GAAP financial measures referenced on this call are reconciled to the most directly comparable GAAP financial measure in a table available in the press release we issued this morning. Before turning the call back to Mark, I want to let everyone know that we'll be making a copy of our prepared remarks for this morning's call available on the investor relations section of our website shortly after the call is completed. We also want to let everyone know that we are going to limit the number of questions to one per person in order to give more people a chance to ask questions within the one hour that has been allotted for this call.